Futurism on MSN4h
Doctors Concerned About Drugmakers Testing Ozempic-Style Injections on Six-Year-Olds
With so many kids already taking weight loss injectables like Ozempic, a new finding from the company behind the blockbuster ...
Daily13h
Eli Lilly invests $1.8 bln in Ireland sites to scale up Alzheimer's, obesity drug production
London: Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely ...
Should You Invest in This Under-the-Radar Weight Loss Stock?
Terns Pharmaceuticals (NASDAQ: TERN) is one of them. The fledgling clinical-stage drugmaker recently reported positive ...
Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.
Whereas Viking Therapeutics saw its shares fly due to favorable phase 2 trial results with its lead candidate, Terns is ...
Is Eli Lilly and Company (LLY) an Unstoppable Dividend Stocks to Buy?
Eli Lilly and Company (NYSE:LLY) was a part of 100 hedge fund portfolios at the end of Q2 2024, down from 109 in the previous ...
Do queasy side effects mean the end of weight-loss drug stock hype?
The bloom may be off the rose for obesity drugs as reports of side effects for high doses of GLP-1 drugs. GLP-1s were ...
The Globe and Mail22h
3 Stocks to Buy and Hold Forever
Its top-selling products this year are likely going to be Zepbound (for weight loss) and Mounjaro (diabetes), and that might not change for the foreseeable future. Innovating, however, is going to be ...
24/7 Wall St. on MSN21h
Not So Fast Jim Cramer, You Should Buy These 3 Stocks He Says to Sell
Jim Cramer is probably the closest thing we have to stock market superstar influencer. The host of CNBC's "Mad Money" show is ...